Profile
Barbara A. Ruskin is currently Director at St. Jude Children's Research Hospital, Inc. since 2007 and President of BA Ruskin Law, LLC since 2012.
Former positions include Director at Burke Neurological Institute from 2016 to 2020, Director at Virpax Pharmaceuticals, Inc. from 2023 to 2024, Associate at Fish & Neave LLP from 1993 to 2004, Chief Patent Officer, Senior VP & General Counsel at Bionor Pharma ASA from 2015 to 2016, Partner at Ropes & Gray LLP from 2005 to 2012, Chief Patent Officer, Senior VP & General Counsel at Molecular Templates, Inc. from 2017 to 2019, and Chief Intellectual Property & Innovation Officer at Silence Therapeutics Plc from 2010 to 2020.
Education includes a doctorate from Harvard University, an undergraduate degree from the University of California, Berkeley, and a graduate degree from Fordham University School of Law.
Barbara Ruskin active positions
| Companies | Position | Start |
|---|---|---|
BA Ruskin Law, LLC | President | 01/05/2012 |
St. Jude Children's Research Hospital, Inc.
St. Jude Children's Research Hospital, Inc. Hospital/Nursing ManagementHealth Services Offers health care and social assistance services for children | Director/Board Member | - |
Former positions of Barbara Ruskin
| Companies | Position | End |
|---|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Director/Board Member | 05/07/2024 |
Burke Neurological Institute
Burke Neurological Institute Pharmaceuticals: MajorHealth Technology Develops novel cures for chronic neurological disabilities | Director/Board Member | 01/03/2020 |
| MOLECULAR TEMPLATES, INC. | General Counsel | 01/02/2019 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Manufactures nutritional supplements and vaccines | General Counsel | 01/08/2016 |
Ropes & Gray LLP
Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/05/2012 |
Training of Barbara Ruskin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Silence Therapeutics Plc
Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
Fish & Neave LLP
Fish & Neave LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services specializing in intellectual property | Commercial Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Jude Children's Research Hospital, Inc.
St. Jude Children's Research Hospital, Inc. Hospital/Nursing ManagementHealth Services Offers health care and social assistance services for children | Health Services |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Manufactures nutritional supplements and vaccines | Health Technology |
Ropes & Gray LLP
Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Fordham University School of Law
Fordham University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BA Ruskin Law, LLC | |
Molecular Templates, Inc.
Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Virpax Pharmaceuticals, Inc.
Virpax Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage pharmaceutical company that develops non-addictive pain and neurological disorders | Commercial Services |
Burke Neurological Institute
Burke Neurological Institute Pharmaceuticals: MajorHealth Technology Develops novel cures for chronic neurological disabilities | Health Technology |
- Stock Market
- Insiders
- Barbara Ruskin
















